Heart failure study seeks smarter diuretic dosing
NCT ID NCT07470554
First seen Apr 02, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This study looks at data from over 4,000 people with severe heart failure to find biological markers that could help doctors choose the right dose of water pills (diuretics). The goal is to create a computer algorithm that personalizes treatment and reduces the risk of death or hospital stays. No new treatments are being tested—instead, researchers are analyzing existing information to improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Heart Failure and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Emilia-Romagna, 40138, Italy
Conditions
Explore the condition pages connected to this study.